Twelve months later, Miller is healthy and preparing to host her family's holiday gathering. A regimen of biological drugs ...

A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.

The annual San Antonio Breast Cancer Symposium was held from Dec. 9 to 12 in San Antonio. Attendees included medical ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Bec Pickering, from Melbourne, has just one wish for her two young daughters after a devastating diagnosis turned her own ...

Apollo Athenaa continues to set new benchmarks in precision oncologyNEW DELHI, /PRNewswire/ -- When a 69-year-old Ms. Maya, a ...

The actress opened up about the importance of connection and community at the San Antonio Breast Cancer Symposium with ...

A Hartlepool woman battling incurable cancer has been praised for raising thousands of pounds for the hospital unit that has ...

A woman who recovered after suffering from stage three bowel cancer has explained how her illness could easily have been missed as she didn't have one of the most common symptoms ...

In its push for more immigrant detention space, the Trump administration is reopening shuttered prisons in several states.

People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly extend their survivorship with fewer toxic side effects, a new study shows.

Investigators evaluated whether the addition of carboplatin to neoadjuvant chemotherapy improved efficacy outcomes in patients with early-stage TNBC.